| Pharmaceutical Information |
| Drug Name |
Kanamycin |
| Drug ID |
BADD_D01226 |
| Description |
Kanamycin (also known as kanamycin A) is an aminoglycoside bacteriocidal antibiotic, available in oral, intravenous, and intramuscular forms, and used to treat a wide variety of infections. Kanamycin is isolated from the bacterium Streptomyces kanamyceticus and its most commonly used form is kanamycin sulfate. |
| Indications and Usage |
For treatment of infections where one or more of the following are the known or suspected pathogens: E. coli, Proteus species (both indole-positive and indole-negative), E. aerogenes, K. pneumoniae, S. marcescens, and Acinetobacter species. |
| Marketing Status |
approved; investigational; vet_approved |
| ATC Code |
A07AA08; J01GB04; S01AA24 |
| DrugBank ID |
DB01172
|
| KEGG ID |
D03262; D00866
|
| MeSH ID |
D007612
|
| PubChem ID |
6032
|
| TTD Drug ID |
D0YV1Q
|
| NDC Product Code |
Not Available |
| UNII |
RUC37XUP2P
|
| Synonyms |
Kanamycin | Kantrex | Kanamycin A | Kanamycin Sulfate |
|
| Chemical Information |
| Molecular Formula |
C18H36N4O11 |
| CAS Registry Number |
59-01-8 |
| SMILES |
C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
